top of page
Home
About Us
Our History
Our Team
Our Faculty
Sustainability
OPC Australia Network
OPC UK Network
OPC Global Network
OPRI Clinical Trials
PREVAIL
MAGNIFY
R & D UK
Research and Development
MAGNIFY
COSMOS
CVAC
Media
Publications
Newsletter
Careers
Contact
< Back
The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study
Apply Now
Job Type
Workspace
About the Role
Requirements
About the Company
Apply Now
bottom of page